Diversity matters in scientific publishing by Kuan-Teh Jeang
Jeang Retrovirology 2012, 9:109
http://www.retrovirology.com/content/9/1/109EDITORIAL Open AccessDiversity matters in scientific publishing
Kuan-Teh JeangAbstract
The importance of geographic diversity in publishing is emphasized in this editorial.Earlier this year, I read about a remarkable change in the
United States population. For the first time in United
States history, the majority (50.4%) of children 1 year and
younger are from minority groups (e.g. Hispanic American,
African American, Asian American etc.. . .). In fact, the face
of America is changing not just amongst her young but in
its totality. Population projections show by the year 2043,
the United States population will exceed 400 million; and
minority groups will compose a majority of this number.
Already four states in the United States (Texas, California,
Hawaii, and New Mexico) are “majority-minority” states
where the combined population of various “minorities”
exceeds the erstwhile “white majority” number.
The face of global science is also changing. I have pre-
viously written about the rise of bioscience in the East
[1]. A Royal Society report (http://royalsociety.org/policy/
projects/knowledge-networks-nations/report/), surveying
the knowledge, networks and nations landscape in 2011,
confirmed this notion and projected that by 2013 the total
number of scientific publications from China published in
English will overtake the counterpart number from the
United States. Anecdotally, in recent years each of us has
seen a steady increase in the number of papers published
in our leading biomedical journals by Chinese and Asian
authors. Surprisingly, in the face of these trends, a long-
standing publishing inherency appears to hold sway. Thus,
last year in a newsletter to its editors, the largest publisher
of biomedical literature Elsevier reported that “while the
spread of countries represented on the editorial boards of
Elsevier journals is ‘reasonable’, countries such as India
and China are under-represented in comparison with their
share of published articles. Interestingly, the percentage of
Elsevier editors from China is 3.3% while nearly 13% of
published articles originate there. Some countries are also
significantly over-represented, for example, 40% of ourCorrespondence: kjeang@nih.gov
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reproduction in any medium, provided the oreditors come from the US while only 18% of published
articles originate there. . .” Needless to say, this imbalance
should be remedied.
In this regard, how is the editorial diversity at Retroviro-
logy? Amongst the 8 Retrovirology editors, 6 are from
countries outside of North America (a 75% non-North
American representation). In Retrovirology’s 60 member
editorial board, 32 individuals hail from outside of North
America (a 53% majority). We believe that diversity is im-
portant because we hold firm the idea that intelligence
and ambition are distributed equally around the globe [2].
One area that we need to do better is to publish more
papers from authors outside of the traditional bastions of
North American and West European science. In exami-
ning all papers published last year, I found that only 10
published Retrovirology papers came from authors based
outside of North America and Western Europe [3-12];
and these papers were submitted from either Australia or
Japan. Although peer-reviewed quality remains the criter-
ion for publication, our goal is to strongly encourage and
work hard in attracting to Retrovirology more manuscripts
from diverse areas of the world. Diversity in science and
scientific publishing matters.
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